GBA's "2021 Stock Phantasma"
- Thread starter stonedinvestor
- Start date
Daily and weekly charts still look a bit heavy, no ?
SNAP?
I mean its pricey. But they are gonna kill the numbers come Feb 4.
Its the new FB. Period. The big money advertisers already know. Grooming a whole new generation.
Ya gotta pay for growth.
All these overnight wonder stocks aside, check out our Gummies for Grandma portfolio.
I put SNAP in there at $37 and it remains one of my #1 picks (as a real stock) for 2021.
Yes its pricey.... but they said that about FB at $30 too.
We'll see.
From yesterday; I actually drew a TA chart lol. Check out that wedgie.
ADMS-
Adamas Pharmaceuticals price target raised to $12.50 from $7.50 at Northland 08:40 ADMS Northland analyst Carl Byrnes raised the firm's price target on Adamas Pharmaceuticals to $12.50 from $7.50 and keeps an Outperform rating on the shares given his view that demand for Gocovri is "well positioned to remain strong." The analyst, who is forecasting 2021 Gocovri sales of $87.5M, added that he thinks that estimate may prove conservative. Further, he expects approval of the sNDA on or about February 1, which will revise the indication statement for Gocovri and broaden the label in a way that will make it easier for healthcare providers to prescribe the drug, the analyst said.
Adamas Pharmaceuticals price target raised to $12.50 from $7.50 at Northland 08:40 ADMS Northland analyst Carl Byrnes raised the firm's price target on Adamas Pharmaceuticals to $12.50 from $7.50 and keeps an Outperform rating on the shares given his view that demand for Gocovri is "well positioned to remain strong." The analyst, who is forecasting 2021 Gocovri sales of $87.5M, added that he thinks that estimate may prove conservative. Further, he expects approval of the sNDA on or about February 1, which will revise the indication statement for Gocovri and broaden the label in a way that will make it easier for healthcare providers to prescribe the drug, the analyst said.
Try to stay on topic here.
We're covering the important stuff.
Hey Stoney, lets me and you start a Pod-Cast.
A Howard Stern for stocks.
Hell I might even pop a gummy or two for that.
Watch Go Pro-- Crawled over $10 yesterday with very large volume reports on Feb 4 should be a very good report I would think. Over $10 can lead to Mutual Fund buying if they smash their number!
You do realize, one quarter of good X-Mas sales does not a great stock make.
Now that said, I bet it has a big short interest too.
And don't tell me about strapping one on to a drone.
All the drones already have beast cameras built in.